VZ5

(14beta,17alpha)-2-ethyl-17-hydroxyestra-1(10),2,4-trien-3-yl sulfamate

Created:	2010-09-08
Last modified:	2011-06-04

Find Related PDB Entry
2 entries where VZ5 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	55
Chiral Atom Count	5
Bond Count	58
Aromatic Bond Count	6

2D diagram of VZ5

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(14beta,17alpha)-2-ethyl-17-hydroxyestra-1(10),2,4-trien-3-yl sulfamate
Systematic Name (OpenEye OEToolkits)	[(8R,9S,13S,14S,17S)-2-ethyl-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] sulfamate
Formula	C₂₀ H₂₉ N O₄ S
Molecular Weight	379.514
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=S(=O)(Oc1cc4c(cc1CC)C3CCC2(C(CCC2O)C3CC4)C)N
SMILES	CACTVS	3.370	CCc1cc2[CH]3CC[C]4(C)[CH](O)CC[CH]4[CH]3CCc2cc1O[S](N)(=O)=O
SMILES	OpenEye OEToolkits	1.7.0	CCc1cc2c(cc1OS(=O)(=O)N)CCC3C2CCC4(C3CCC4O)C
Canonical SMILES	CACTVS	3.370	CCc1cc2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCc2cc1O[S](N)(=O)=O
Canonical SMILES	OpenEye OEToolkits	1.7.0	CCc1cc2c(cc1OS(=O)(=O)N)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C
InChI	InChI	1.03	InChI=1S/C20H29NO4S/c1-3-12-10-16-13(11-18(12)25-26(21,23)24)4-5-15-14(16)8-9-20(2)17(15)6-7-19(20)22/h10-11,14-15,17,19,22H,3-9H2,1-2H3,(H2,21,23,24)/t14-,15+,17-,19-,20-/m0/s1
InChIKey	InChI	1.03	POSDSPVRJAJSEI-SSGANFLRSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL366014
PubChem	11211176
ChEMBL	CHEMBL366014

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.